| |
All LHID2000
| |
HBV
| | |
HCV
| |
|---|
|
Cancer type
|
Events
|
Ratea
|
Events
|
Ratea
|
IRRb
|
(95 % CI)
|
Events
|
Ratea
|
IRRb
|
(95 % CI)
|
|---|
|
Overall
|
40213
|
36.59
|
1330
|
94.01
|
2.95
|
(2.80–3.12)*
|
1232
|
163.00
|
3.33
|
(3.15–3.53)
|
|
Brain cancer
|
509
|
0.46
|
7
|
0.49
|
1.13
|
(0.53–2.38)
|
7
|
0.93
|
1.61
|
(0.76–3.39)
|
|
Head and neck cancer
|
4079
|
3.71
|
66
|
4.67
|
1.23
|
(0.97–1.57)
|
48
|
6.35
|
1.43
|
(1.08–1.90)*
|
|
Thyroid gland cancer
|
1138
|
1.04
|
24
|
1.70
|
1.78
|
(1.19–2.67)*
|
13
|
1.72
|
1.53
|
(0.89–2.65)
|
|
Esophageal cancer
|
850
|
0.77
|
15
|
1.06
|
1.45
|
(0.87–2.42)
|
11
|
1.46
|
1.48
|
(0.82–2.68)
|
|
Stomach cancer
|
2247
|
2.04
|
32
|
2.26
|
1.42
|
(1.00–2.01)*
|
37
|
4.90
|
1.78
|
(1.28–2.46)*
|
|
Colorectal cancer
|
5890
|
5.36
|
104
|
7.35
|
1.69
|
(1.39–2.05)*
|
83
|
10.98
|
1.51
|
(1.21–1.87)*
|
|
Liver cancer
|
5293
|
4.82
|
770
|
54.43
|
12.89
|
(11.9–13.9)*
|
782
|
103.46
|
16.26
|
(15.1–17.5)*
|
|
Gallbladder and extrahepatic bile duct cancer
|
501
|
0.46
|
14
|
0.99
|
2.80
|
(1.64–4.76)*
|
18
|
2.38
|
3.81
|
(2.38–6.10)*
|
|
Pancreatic cancer
|
684
|
0.62
|
19
|
1.34
|
2.73
|
(1.73–4.31)*
|
17
|
2.25
|
2.66
|
(1.65–4.31)*
|
|
Lung cancer
|
4656
|
4.24
|
74
|
5.23
|
1.57
|
(1.25–1.97)*
|
69
|
9.13
|
1.61
|
1.27–2.04)*
|
|
Kidney cancer
|
1065
|
0.97
|
28
|
1.98
|
2.47
|
(1.70–3.60)*
|
17
|
2.25
|
1.71
|
(1.06–2.76)*
|
|
Bladder cancer
|
1324
|
1.20
|
24
|
1.70
|
1.83
|
(1.22–2.74)*
|
24
|
3.18
|
1.98
|
(1.33–2.97)*
|
|
Uterine and corpus cancerc
|
600
|
1.10
|
14
|
2.29
|
2.12
|
(1.25–3.61)*
|
11
|
2.98
|
2.17
|
(1.19–3.93)*
|
|
Cervical cancerc
|
1877
|
3.43
|
10
|
1.64
|
0.51
|
(0.27–0.95)
|
11
|
2.98
|
0.62
|
(0.34–1.12)
|
|
Ovarian cancerc
|
592
|
1.08
|
15
|
2.45
|
2.29
|
(1.37–3.82)*
|
8
|
2.16
|
1.67
|
(0.83–3.35)
|
|
Prostate cancerd
|
1820
|
3.30
|
30
|
3.73
|
1.83
|
(1.28–2.63)*
|
24
|
6.21
|
1.55
|
(1.04–2.32)*
|
|
Breast cancerc
|
4695
|
8.58
|
74
|
12.10
|
1.43
|
(1.14–1.80)*
|
46
|
12.45
|
1.17
|
(0.87–1.56)
|
|
Melanoma
|
136
|
0.12
|
0
|
--
|
--
|
--
|
2
|
0.26
|
1.58
|
(0.39–6.37)
|
|
Skin cancer
|
619
|
0.56
|
15
|
1.06
|
2.44
|
(1.46–4.08)*
|
11
|
1.46
|
1.90
|
(1.04–3.44)*
|
|
Non-Hodgkin’s lymphoma
|
738
|
0.67
|
22
|
1.56
|
2.58
|
(1.69–3.94)*
|
20
|
2.65
|
3.01
|
(1.93–4.69)*
|
|
Myeloma
|
218
|
0.20
|
2
|
0.14
|
0.87
|
(0.22–3.49)
|
3
|
0.40
|
1.47
|
(0.47–4.60)
|
|
Leukemia
|
682
|
0.62
|
15
|
1.06
|
1.82
|
(1.09–3.04)*
|
7
|
0.93
|
1.19
|
(0.56–2.50)
|
- IRR incidence rate ratio
- aPer 10,000 person-years
- bAdjusted for sex and age
- cWomen only
- dMen only
- *p< 0.05
